help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, Y. M.
Right arrow Articles by Conigrave, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, Y. M.
Right arrow Articles by Conigrave, A. D.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 2 605-610
Copyright © 2003 by The Endocrine Society

Autosomal Dominant Hypocalcemia: A Novel Activating Mutation (E604K) in the Cysteine-Rich Domain of the Calcium-Sensing Receptor

Y. M. Tan, J. Cardinal, A. H. Franks, H.-C. Mun, N. Lewis, L. B. Harris, J. B. Prins and A. D. Conigrave

Department of Medicine (Y.M.T.), Townsville Hospital, Townsville, Queensland 4810; Department of Diabetes and Endocrinology (J.C., J.B.P.), Princess Alexandra Hospital, Woolloongabba, Queensland 4102; and School of Molecular and Microbial Biosciences (A.H.F., H.-C.M., N.L., L.B.H., A.D.C.), University of Sydney, Sydney, New South Wales 2006, Australia

Address all correspondence and requests for reprints to: A/Prof. Arthur D. Conigrave, Department of Biochemistry (G08), University of Sydney, NSW 2006, Australia. E-mail: a.conigrave{at}mmb.usyd.edu.au.

We report a novel activating mutation (E604K) of the calcium-sensing receptor in a family with autosomal dominant hypocalcemia. Whereas all affected individuals exhibited marked hypocalcemia, some cases with untreated hypocalcemia exhibited seizures in infancy, whereas others were largely asymptomatic from birth into adulthood. The missense mutation E604K (G2182A; GenBank accession no. U20759), which affects an amino acid residue in the C terminus of the cysteine-rich domain of the extracellular head, cosegregated with hypocalcemia in all seven individuals for whom DNA was available. Two unaffected, normocalcemic members of the family did not exhibit the mutation. The molecular impact of the mutation on two key components of the signaling response was assessed in HEK-293 cells transiently transfected with cDNA corresponding to either the wild-type calcium-sensing receptor or the E604K mutation derived by site-directed mutagenesis. There was a significant leftward shift in the concentration response curves for the effects of extracellular Ca2+ on both intracellular Ca2+ mobilization (determined by aequorin luminescence) and MAPK activity (determined by luciferase expression). The C terminus of the cysteine-rich domain of the extracellular head may normally act to suppress receptor activity in the presence of low extracellular Ca2+ concentrations.

A.D.C.’s research is supported by the National Health and Medical Research Council of Australia.

Abbreviations: ADH, Autosomal dominant hypocalcemia; CaR, calcium-sensing receptor; Cys-rich, cysteine-rich; PI-PLC, phosphoinositide-specific phospholipase C; VFT, Venus Fly-Trap.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. Pidasheva, M. Grant, L. Canaff, O. Ercan, U. Kumar, and G. N. Hendy
Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly
Hum. Mol. Genet., July 15, 2006; 15(14): 2200 - 2209.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. D. Mittelman, G. N. Hendy, R. A. Fefferman, L. Canaff, I. Mosesova, D. E. C. Cole, L. Burkett, and M. E. Geffner
A Hypocalcemic Child with a Novel Activating Mutation of the Calcium-Sensing Receptor Gene: Successful Treatment with Recombinant Human Parathyroid Hormone
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2474 - 2479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-C. Mun, E. L. Culverston, A. H. Franks, C. A. Collyer, R. J. Clifton-Bligh, and A. D. Conigrave
A Double Mutation in the Extracellular Ca2+-sensing Receptor's Venus Flytrap Domain That Selectively Disables L-Amino Acid Sensing
J. Biol. Chem., August 12, 2005; 280(32): 29067 - 29072.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Wystrychowski, S. Pidasheva, L. Canaff, J. Chudek, F. Kokot, A. Wiecek, and G. N. Hendy
Functional Characterization of Calcium-Sensing Receptor Codon 227 Mutations Presenting as Either Familial (Benign) Hypocalciuric Hypercalcemia or Neonatal Hyperparathyroidism
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 864 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-C. Mun, A. H. Franks, E. L. Culverston, K. Krapcho, E. F. Nemeth, and A. D. Conigrave
The Venus Fly Trap Domain of the Extracellular Ca2+-sensing Receptor Is Required for L-Amino Acid Sensing
J. Biol. Chem., December 10, 2004; 279(50): 51739 - 51744.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. N. Hendy, C. Minutti, L. Canaff, S. Pidasheva, B. Yang, Z. Nouhi, D. Zimmerman, C. Wei, and D. E. C. Cole
Recurrent Familial Hypocalcemia Due to Germline Mosaicism for an Activating Mutation of the Calcium-Sensing Receptor Gene
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3674 - 3681.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society